SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community.

Ben Avraham, B; Crespo-Leiro, MG; Filippatos, G; Gotsman, I; Seferovic, P; Hasin, T; Potena, L; Milicic, D; Coats, AJS; Rosano, G; et al. Ben Avraham, B; Crespo-Leiro, MG; Filippatos, G; Gotsman, I; Seferovic, P; Hasin, T; Potena, L; Milicic, D; Coats, AJS; Rosano, G; Ruschitzka, F; Metra, M; Anker, S; Altenberger, J; Adamopoulos, S; Barac, YD; Chioncel, O; De Jonge, N; Elliston, J; Frigeiro, M; Goncalvesova, E; Grupper, A; Hamdan, R; Hammer, Y; Hill, L; Itzhaki Ben Zadok, O; Abuhazira, M; Lavee, J; Mullens, W; Nalbantgil, S; Piepoli, MF; Ponikowski, P; Ristic, A; Ruhparwar, A; Shaul, A; Tops, LF; Tsui, S; Winnik, S; Jaarsma, T; Gustafsson, F; Ben Gal, T (2021) HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community. ESC Heart Fail, 8 (6). pp. 4394-4408. ISSN 2055-5822 https://doi.org/10.1002/ehf2.13588
SGUL Authors: Rosano, Giuseppe Massimo Claudio

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview

Abstract

The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient-device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the 'destination therapy' indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.

Item Type: Article
Additional Information: © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/0 License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: CPR, Emergency medical systems, General description, LVAD, LVAD, General description, Emergency medical systems, CPR
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: ESC Heart Fail
ISSN: 2055-5822
Language: eng
Dates:
DateEvent
27 December 2021Published
14 September 2021Published Online
19 August 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 34519177
Web of Science ID: WOS:000695923400001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113715
Publisher's version: https://doi.org/10.1002/ehf2.13588

Actions (login required)

Edit Item Edit Item